ArticleEuropean geriatric medicine2026
Bridging the gap in delirium management: a European comparison of geriatric practices.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo compare diagnostic and therapeutic approaches to delirium across European countries with well-established (WE) versus less-developed (LE) geriatric medicine (GM), to identify similarities, differences and potential gaps in care.
methodsA cross-sectional online survey was conducted among European geriatricians via the European Geriatric Medicine Society and professional networks from July 2023 to March 2024. Responses on delirium diagnosis and management were analyzed quantitatively, with comparisons between WE and LDGM countries.
resultsOf 196 hospital-based respondents, 79.1% were from WEGM countries and 20.9% from LDGM countries. Structured delirium screening was significantly more common in WEGM nations, especially in geriatric (88.4% vs 43.9%, p < 0.001) and orthopedic wards. Non-pharmacological strategies-such as hydration support (76.8% vs 52.5%, p = 0.002) and family involvement (81.5% vs 60.4%, p = 0.005)-were also more frequently used. Conversely, physical restraints were more commonly employed in LDGM countries (70.7% vs 41.4%, p < 0.001), as were pharmacological treatments, such as trazodone and quetiapine.
conclusionMarked differences exist in delirium management across Europe, which may be linked at least in part to GM development, although confounding factors may exist, and causality cannot be assumed. WEGM countries appear to prioritize structured screening and non-pharmacological interventions, whereas LDGM countries rely more on pharmacological treatments. These findings highlight the need for standardized European guidelines to ensure equitable delirium care.
Indexed as
Identifiers
42374003What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.